Good update in independent biotech magazine on all this about PNV. Lots of good news to come. Next 12 -18 months should be transformative, especially if new product filing is achieved. BARDA is still actively supporting them and paying for studies. Hold on. PNV future is bright. All of this is annoying and unfortunate for us long term holders as it erodes confidence and wealth!. Have held for 17 years. Am not going to run because of a journalist sensationalised headlines. There are obviously issues at management level. If this is the conclusion of the review we either accept it or move to another company. I feel sorry for SR however as he appears a very honest, quietly spoken man with strong values. There are lots of long term holders who are down millions of dollars who are holding on for better days that will surely come. regards Bill
PNV Price at posting:
$1.20 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)